Oxidative stress and neurotrophin signaling in autism

Autism: Oxidative Stress, Inflammation, and Immune Abnormalities

Volumn , Issue , 2009, Pages 47-60

  Sajdel Sulkowska, Elizabeth M ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85057396489     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (93)

1. Abdollahi, M., Ranjbar, A., Shadnia S., Nikfar, S., and Rezaiee, A. (2004). Pesticides and oxidative stress: A review. Med. Sci. Monit. 10:141-147.
2. Baird, G., Charman, T., Baron-Cohen, S., Cox, A., Swettenham, J., Wheelwright, S., and Drew, A. (2000). A screening instrument for autism at 18 months of age: A 6-year follow-up study. J. Am. Acad. Child Adolesc. Psychiatry 39:694-702.
3. Ballerio, R., Ginazza, E., Mussoni, L., Miller, I., Gelosa, P., Guerrini, U., Eberini, I., Gemeiner, M., Belcredito, S., Tremoli, E., and Sironi, L. (2007). Gender differences in endothelial function and inflammatory markers align the occurrence of pathological events in stroke-prone rats. Exp. Mol. Pathol. 82:33-41.
4. Bates, B., Hirt, L., Thomas, S. S., Akbarian, S., Le, D., Amin-Hanjani, S., Whalen, M., Jaenisch, R., and Moskowitz, M. A. (2002). Neurotrophin-3 promotes cell death induced in cerebellar ischemia, oxygen-glucose deprivation, and oxidative stress: Possible involvement of oxygen free radicals. Neurobiol. Dis. 9:24-37.
5. Beal, M. F. (2002). Oxidatively modified proteins in aging and disease. Free Radic. Biol. Med. 32:797-803.
6. Beckman, J. S. and Koppenol, W. H. (1996). Nitric oxide, superoxide, and peroxynitrite the good, the bad and the ugly. Am. J. Physiol. 271:c1424-c1437.
7. Behrens, M. M., Strasser, U., Lobner, D., and Dugan, L. L. (1999). Neurotrophin-mediated potentiation of neuronal injury. Microsc. Res. Tech. 45:276-284.
8. Betancourt, A. M., Filipov, N. M., and Carr, L. R. (2007). Alteration of neurotrophins in the hippocampus and cerebral cortex of young rats exposed to chlorpyrifos and methyl parathion. Toxicol. Sci. 100:445-455.
9. Binder, D. K., Croll, S. D., Gall, C. M., and Scharfman, H. E. (2001). BDNF and epilepsy: Too much of a good thing? Trends Neurosci. 24:318-319.
10. Bokara, K. K., Brown, E., McCormick, R., Yallapragada, P. R., Rajanna, S., and Bettaiya, R. (2008). Lead-induced increase in antioxidant enzymes and lipid peroxidation products in developing rat brain. Biometals 21:9-16.
11. Bradstreet, J., Geier, D. A., Kartzinel, J. J., Adams, J. B., and Geier, M. R. (2003). A casecontrol study of mercury burden in children with autistic disorders. J. Am. Phys. Surg. 8:76-80.
12. Brown, G. E., Jones, S. D., MacKewn, A. S., and Plank, E. J. (2008). An exploration of possible pre- and postnatal correlates of autism: A pilot survey. Psychol. Rep. 102:273-282.
13. Buyske, S., Williams, T. A., Mars, A. E., Stenroos, E. S., Ming, S. X., Wang, R., Sreenath, M., Factura, M. F., Reddy, C., Lambert, G. H., and Johnson, W. G. (2006). Analysis of case-parent trios at a locus with a deletion allele: Association of GSTM1 with autism. BMC Genet. 7:8.
14. Cappelletti, G., Maggioni, M. G. Tedeschi, G., and Maci, R. (2003). Protein tyrosine nitration is triggered by nerve growth factor during neuronal differentiation of PC12 cells. Exp. Cell. Res. 288:9-20.
15. Chao, S. L., Moss, J. M., and Harry, G. J. (2007). Lead-induced alterations of apoptosis and neurotrophic factor mRNA in the developing rat cortex, hippocampus, and cerebellum. J. Biochem. Mol. Toxicol. 21:265-272.
16. Chauhan, A. and Chauhan, V. (2006). Oxidative stress in autism. Pathophysiology 13:171-181.
17. Chauhan, A., Chauhan, V., Brown, W. T., and Cohen, I. (2004). Oxidative stress in autism: Increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin-the antioxidant proteins. Life Sci. 75:2539-2549.
18. Chen, W. G., Chang, Q., Lin, Y., Meissner, A., West, A. E., Griffith, E. C., Jaenisch, R., and Greeberg, M. E. (2003). Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302:885-889.
19. Connolly, A. M., Chez, M., Streif, E. M., Keeling, R. M., Golumbek, P. T., Kwon, J. M., Riviello, J. J., Robinson, R. G., Neuman, R. J., and Deuel, R. M. K. (2006). Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biol. Psychiatry 59:354-363.
20. Courchesne, E. (1991). Neuroanatomic imaging in autism. Pediatrics 87:781-790.
21. Courchesne, E., Carper, R., and Akshoomoff, N. (2003). Evidence of brain overgrowth in the first year life in autism. JAMA 290:393-394.
22. Courchesne, E., Karns, C. M., Davis, H. R., Ziccardi, R., Carper, R. A., and Tigue, Z. D. (2001). Unusual brain growth patterns in early life in patients with autistic disorder: An MRI study. Neurology 57:245-254.
23. Dam, K., Seidler, F. J., and Slotkin, T. A. (2000). Chlorpyrifos exposure during a critical neonatal period elicits gender-selective deficits in the development of coordination skill and locomotor activity. Brain Res. Dev. Brain Res. 121:179-187.
24. D’Amelio, M., Ricci, I., Sacco, R., Liu, X., D’Agruma, L., Muscarella, L.A., Guarnieri, V., Militerni, R., Bravaccio, C., Elia, M., Schneider, C., Melmed, R., Trillo, S., Pascucci, T., Puglisi-Allegra, S., Reichelt, K. L., Macciardi, F., Holden, J.J., and Persico, A. M. (2005). Paraoxonase gene variants are associated with autism in North America, but not in Italy: Possible regional specificity in gene-environment interactions. Mol. Psychiatry 10:1006-1016.
25. Das, K. P., Chao, S. L., White, L. D., Haines, W. T., Harry, G. J., Tilson, H. A., and Barone, Jr. S. (2001). Differential patterns of nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 mRNA and protein levels in developing regions of rat brain. Neuroscience 103:739-761.
26. de Cabo, C. and Viveros, M. P. (1997). Effects of neonatal naltrexone on neurological and somatic development in rats of both genders. Neurotoxicol. Teratol. 19:499-509.
27. Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean. M., Lu, B., and Weinberger, D. R. (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112:257-269.
28. Enstrom, A., Onore, C., Tarver, A., Hertz-Picciotto, I., Hansen, R., Croen, L., Van de Walter, J., and Ashwood, P. (2008). Peripheral blood leukocyte production of BDNF following mitogen stimulation in early onset and regressive autism. Am. J. Biochem. Biotechnol. (Special Issue on Autism Spectrum Disorders) 4:121-129.
29. Ferguson, S. A., Paule, M. G., and Holson, R. R. (1996). Functional effects of methylazoxymethanol-induced cerebellar hypoplasia in rats. Neurotoxicol. Teratol. 18:529-537.
30. Fukuda, M., Yamaguchi, H., Yamamoto, H., Aminaka, M., Murakami, H., Kamiyama, N., Miyamoto, Y., and Koitabashi, Y. (2008). The evaluation of oxidative damage in children with brain damage using 8-hydroxydeoxyguanosine levels. Brain Dev. 30:131-136.
31. Ghosh, A. and Greenberg, M. E. (1995). Distinct roles for bFGF and NT-3 in the regulation of cortical neurogenesis. Neuron 15:89-103.
32. Gilmore, J. H., Jarskog, L. F., and Vadlamudi, S. (2003). Maternal infection regulates BDNF and NGF expression in fetal and neonatal brain and maternal-fetal unit of rat. J. Neuroimmunol. 138:49-55.
33. Hashimoto, K., Iwata, Y., Nakamura, K., Tsuji, M., Tsuchiya, K. J., Sekine, Y., Suzuki, K., Minabe, Y., Takei, N., Iyo, M., and Mori, N. (2006). Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism. Prog. Neuropsychopharmacol. Biol. Psychiatry 30:1529-1531.
34. James, S. J., Cutler, P., Melnyk, S., Jernigan, S., Janak, L., Gaylor, D. W., and Neubrander, J. A. (2004). Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am. J. Clin. Nutr. 80:1611-1617.
35. James, S. J., Melny, S., Jernigan, S., Cleves, M. A., Halsted, C. H., Wong, D. H., Cutler, P., Bock, K., Boris, M., Bradstreet, J. J., Baker, S. M., and Gaylor, D. W. (2006). Metabolic endotype and related genotypes are associated with oxidative stress in children with autism. Am. J. Genet. B. Neuropsychiat. Genet. 141:947-956.
36. Katoh-Semba, R., Wakako, R., Komori, T., Shigemi, H., Miyazaki, N., Ito, H., Kumagai, T., Isuzuki, M., Shigemi, K., Yoshida, F., and Nakayama, A. (2007). Age-related changes in BDNF protein levels in human serum: Differences between autism cases and normal controls. Int. J. Dev. Neurosci. 25:367-372.
37. Kawakami, H., Nitta, A., Matsuyama, Y., Kamiya, M., Satake, K., Sato, K., Kondou, K., Iwata, H., and Furukawa, S. (2000). Increase in neurotrophin-3 expression followed by Purkinje cell degeneration in the adult rat cerebellum after spinal cord transaction. J. Neurosci. Res. 62:668-674.
38. Kemper, T. L. and Bauman, M. L. (1993). The contribution of neuropathologic studies to the understanding of autism. Neurol. Clin. 11:175-187.
39. Kimura-Kuroda, J., Nagata, I., and Kuroda, Y. (2007). Disrupting effect of hydroxylpolychlorinated biphenyl (PCB) congeners on neuronal development of cerebellar Purkinje cells: A possible causal factor for the developmental brain disorders. Chemosphere 67:S412-S420.
40. Klinstova, A. Y., Dickson, E., Yoshida, R., and Greenough, W. T. (2004). Altered expression of BDNF and its high affinity receptor TrkB in response to complex motor learning and moderate exercise. Brain Res. 1028:92-104.
41. Lante, F., Meunier, J., Guiramand, J., Maurice, T., Cavalier, M., de Jesus Ferriera, M. C., Aimar, R., Cohen-Solal, C., Vignes, M., and Barbanel, G. (2007). Neurodevelopmental damage after prenatal infection: Role of oxidative stress in the fetal brain. Free Radic. Biol. Med. 42:1231-1245.
42. Lee, S. H., Kim, I., and Chung, B. C. (2007). Increased urinary level of oxidized nucleosides in patients with mild-to-moderate Alzheimer’s disease. Clin. Biochem. 40:936-938.
43. Li, S., Qiu, F., Xu, A., Price, S. M., and Xiang, M. (2004). Barhl1 regulates migration and survival of cerebellar granule cells by controlling expression of neurotrophin-3 gene. J. Neurosci. 24:3104-3114.
44. Loat, C., Curran, S., Lewis, C., Abrahams, B., Duvall, J., Geschwind, D., Bolton, P., and Craig, I. (2008). Methyl-CpG-binding protein (MECP2) polymorphism and vulnerability to autism. Genes Brain Behav. 7:754-760.
45. Lovell, M. A., Gabbita, S. P., and Markesbery, W. R. (1999). Increased DNA oxidation and decreased levels of repair products in Alzheimer’s disease ventricular CSF. J. Neurochem. 72:771-776.
46. Markowski, V. P., Cox, C., and Weiss, B. (1998). Prenatal cocaine exposure produces gender-specific motor effects in aged rats. Neurotoxicol. Teratol. 20: 43-53.
47. Marx, C. E., Vance, B. J., Jarskog, L. F., Chescheir, N. C., and Gilmore, J. H. (1999). Nerve growth factor, brain derived neurotrophic factor, and neurotrophin-3 levels in human amniotic fluid. Am. J. Obstet. Gynecol. 181:1225-1230.
48. McGinnis, W. R. (2004). Oxidative stress in autism. Altern. Ther. Health Med. 10:22-37.
49. Mecocci, P., Polidori, M. C., Cherubini, A., Ingegni, T., Mattioli, P., Catani, M., Rinaldi, P., Cechetti, R., Stahl, W., Senin, U., and Beal, M. F. (2002). Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. Arch. Neurol. 59:794-798.
50. Ming, X., Stein, T. P., Brimacombe, M., Johnson, W. G., Lambert, G. H., and Wagner, G. C. (2005). Increased excretion of lipid peroxidation biomarker in autism. Prostaglandins Leukot. Essent. Fatty Acids 73:379-384.
51. Miyazaki, K., Narita, N., Sakuta, R., Miyahara, T., Naruse, H., Okado, N., and Narita, M. (2004). Serum neurotrophin concentrations in autism and mental retardation: A pilot study. Brain Dev. 26:292-295.
52. Morrison, M. E. and Mason, C. A. (1998). Granule neuron regulation of Purkinje cell development: Striking a balance between neurotrophin and glutamate signaling. J. Neurosci. 18:3563-3573.
53. Mutter, J., Naumann, J., Schneider, R., Walach, H., and Haley, B. (2005a). Mercury and autism: Accelerating evidence? Neuro. Endocrinol. Lett. 26:439-446.
54. Mutter, J., Naumann, J., Walach, H., and Daschner, F. (2005b). Amalgam risk assessment with coverage of references up to 2005. Gesundheitswesen 67:204-216.
55. Nelson, K. B., Grether, J. K., Croen, L. A., Dambrosia, J. M., Dickens, B., Jelliffe, L. L., Hansen, R. L., and Philips, T. M. (2001). Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann. Neurol. 49:597-606.
56. Nelson, P. G., Kuddo, T., Song, E. Y., Dambrosia, J. M., Kohler, S., Satyanarayana, G., Vandunk, C., Grether, J. K., and Nelson, K. B. (2006). Selected neuropeptides and cytokines: Developmental trajectory and concentrations in neonatal blood of children with autism or Down syndrome. Int. J. Dev. Neurosci. 241:73-80.
57. Neumann, H., Hazen, L., Weinstein, J., Mehl, R. A., and Chin, J. W. (2008). Genetically encoding protein oxidative damage. J. Am. Chem. Soc. 130:4028-4033.
58. Nishimura, K., Nakamura, K., Anitha, A., Yamada, K., Tsuji, M., and Iwayama, Y. (2007). Genetic analyses of the brain-derived neurotrophic factor (BDNF) gene in autism. Biochem. Biophys. Res. Commun. 356:200-206.
59. Nishioka, N. and Arnold, S. E. (2004). Evidence for oxidative DNA damage in the hippocampus of elderly patients with chronic schizophrenia. Am. J. Geriatr. Psychiatry 12:167-175.
60. Ogier, M., Wang, H., Hong, E., Wang, Q., Greenberg, M. E., and Katz, D. M. (2007). Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome. J. Neurosci. 27:10912-10917.
61. Palmer, R. F., Blanchard, S., and Wood, R. (2009). Proximity to point sources of environmental mercury release as a predictor of autism prevalence. Health Place 15:18-24.
62. Pasarica, D., Gheorghiu, M., Toparceanu, F., Bleotu, C., Ichim, L., and Trandafir, T. (2005). Neurotrophin-3, TNF-alpha and IL-6 relations in serum and cerebrospinal fluid of ischemic stroke patients. Roum. Arch. Microbiol. Immunol. 64:27-33.
63. Perry, E. K., Lee, M. W., Martin-Ruiz, C. M., Court, J. A., Volsen, S. G., Merrit, J., Folly, E., Iversen, P. E., Bauman, M. L., Perry, R. H., and Wenk, G. L. (2001). Cholinergic activity in autism: Abnormalities in the cerebral cortex and basal forebrain. Am. J. Psychiatry 158:1058-1066.
64. Quartu, M., Lai, M. L., and Del Fiacco, M. (1999). Neurotrophin-like immunoreactivity in the human hippocampal formation. Brain Res. Bull. 48:375-382.
65. Reichardt, L. F. (2006). Neurotrophin-regulated signaling pathway. Phil. Trans R. Soc. B 361:1545-1564.
66. Ren, J. (2007). Influence of gender on oxidative stress, lipid peroxidation, protein damage and apoptosis in hearts and brains from spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 34:432-438.
67. Rintala, J., Jaatinen, P., Kiianmaa, K., Iikonen, J., Kemppainen, O., Sarviharju, M., and Hervonen, A. (2001). Dose-dependent decrease in glial fibrillary acidic proteinimmunoreactivity in rat cerebellum after lifelong ethanol consumption. Alcohol 23:1-8.
68. Rivto, E. R., Freeman, B. J., Scheibel, A. B., Duong, T., Robinson, H., Guthrie, D., and Ritvo, A. (1986). Lower Purkinje cell counts in the cerebella of four autistic subjects: Initial findings of the UCLA-NSac Autopsy Research Report. Am. J. Psychiatry 143:862-866.
69. Rout, U. K. and Dhossche, D. M. (2008). A pathogenetic model of autism involving Purkinje cell loss through anti GAD antibodies. Med. Hypotheses 71:218-221.
70. Sacksteder, C. A., Qian, W. J., Knyushko, T. V., Wang, H., Chin, M. H., Lacan, G., Melega, W. P., Camp, D. G. II, Smith, R. D., Smith, D. J., Squier, T. C., and Bigelow, D. J. (2006). Endogenously nitrated proteins in mouse brain: Links to neurodegenerative disease. Biochemistry 45:8009-8022.
71. Sadakata, T., Washida, M., Iwayama, Y., Shoji, S., Sato, Y., and Ohkura, T. (2007). Autistic-like phenotypes in Cadps2-knockout mice and aberrant CADPS2 splicing in autistic patients. J. Clin. Invest. 117:931-943.
72. Sajdel-Sulkowska, E. M., Lipinski, B., Windom, H., Audhya, T., and McGinnis, W. (2008). Oxidative stress in autism: Cerebellar 3-nitrotyrosine levels. Am. J. Biochem. Biotechnol. (Special Issue on Autism Spectrum Disorders) 4:73-84.
73. Sajdel-Sulkowska, E. M., Ming, X., and Koibuchi, N. (2009). Increase in brain neurotrophin-3 and oxidative stress in autism. Cerebellum [Epub PMID 19357934].
74. Sato, S., Mizuno, Y., and Hattori, N. (2005). Urinary 8-hydroxydeoxyguanosine levels as a biomarker for progression of Parkinson disease. Neurology 64:1081-1083.
75. Scott, F. J., Baron-Cohen, S., Bolton, P., and Brayne, C. (2002). Brief report: Prevalence of autism spectrum conditions in children aged 5-11 years in Cambridgeshire, UK. Autism 6:231-237.
76. Segal, R. A., Pomeroy, S. L., and Stiles, C. D. (1995). Axonal growth and fasciculation linked to differential expression of BDNF and NT-3 receptors in developing granule cells. J. Neurosci. 15:4970-4981.
77. Serajee, F. J., Nabi, R., Zhong, H., and Huq, M. (2004). Polymorphism in xenobiotic metabolism genes and autism. J. Child Neurol. 19:413-417.
78. Sogut, S., Zoroglu, S. S., Ozyurt, H., Yilmaz, H. R., Ozuğurlu, F., Sivasli, E., Yetkin, O., Yanik, M., Tutkun, H., Savaş, H. A., Tarakçioğlu, M., and Akyol, O. (2003). Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathological mechanisms involved in autism. Clin. Chim. Acta 33:1111-1117.
79. Sultana, R., Perluigi, M., and Butterfield, D. A. (2006). Protein oxidation, lipid peroxidation in brain of subjects with Alzheimer’s disease: Insights into mechanism of neurodegeneration from redox proteomics. Antioxid. Redox. Signal. 8:2021-2037.
80. Sweeten, T. L., Posey, D. J., Shankar, S., and McDougle, C. J. (2004). High nitric oxide production in autistic disorder: A possible role for interferon-gamma. Biol. Psychiatry 55:434-437.
81. Tabuchi, A. (2008). Synaptic plasticity-regulated gene expression: A key event in the longlasting changes of neuronal function. Biol. Pharm. Bull. 31:327-335.
82. Tsai, S. J. (2005). Is autism caused by early hyperactivity of brain derived neurotrophic factor? Med. Hypotheses 65:79-82.
83. Tsai, S. J. (2007). Semax, an analogue of adrenocorticotropin (4-10), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome. Med. Hypotheses 68:1144-1146.
84. Vargas, M. R., Pehar, M., Cassina, P., Estavez, A. G., Beckman, J. S., and Barbeito, L. (2004). Stimulation of nerve growth factor expression in astrocytes by peroxynitrite. In Vivo 18:269-274.
85. Vicedomini, J. P., Nonneman, A. J., DeKosky, S. T., and Scheff, S. W. (1986). Perinatal glucocorticoids disrupt learning: A sexually dimorphic response. Physiol. Behav. 36:145-149.
86. Whitney, E. R., Kemper, T. L., Bauman, M. L., Rosene, D. L., and Blatt, G. J. (2008). Cerebellar Purkinje cells are reduced in a subpopulation of autistic brains: A stereological experiment using calbindin-D28k. Cerebellum 7:406-416.
87. Windham, G. C., Zhang, L., Gunier, R., Croen, L. A., and Grether, J. K. (2006). Autism spectrum disorders in relation to distribution of hazardous air pollutants in the San Francisco bay area. Environ. Health Perspect. 114:1438-1444.
88. Yang, I. A., Fong, K. M., Zimmerman, P. V., Holgate, S. T., and Holloway, J. W. (2008). Genetic susceptibility to the respiratory effects of air pollution. Thorax 63:555-563.
89. Yao, Y., Walsh, W. J., McGinnis, W. R., and Pratico, D. (2006). Altered vascular phenotype in autism: Correlation with oxidative stress. Arch. Neurol. 63:1161-1164.
90. Yip, J., Soghomonian, J. J., and Blatt, G. J. (2007). Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: Pathophysiological implications. Acta Neuropathol. 113:559-568.
91. Yorbik, O., Sayal, A., Akay, C., Akbiyik, D. I., and Sohmen, T. (2002). Investigation of antioxidant enzymes in children with autistic disorder. Prostaglandins Leukot. Essent. Fatty Acids 67:341-343.
92. Zhu, S.-W., Pham, T. M., Aberg, E., Brene, S., Winblad, B., Mohammed, A. H., and Baumans, V. (2006). Neurotrophin levels and behavior in BALB/c mice: Impact of intermittent exposure to individual housing and wheel running. Behav. Brain Res. 167:1-8.
93. Zoroglu, S. S., Armutcu, F., Ozen, S., Gurel, A., Sivasli, E., Yetkin, O., and Meram, I. (2004). Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism. Eur. Arch. Psychiatr. Clin. Neurosci. 254:143-147.